Trifecta-Lung cfDNA-MMDx Study: Comparing the Dd-cfDNA Test to MMDx Microarray Test and Central HLA Antibody Test
Status: Recruiting
Location: See all (16) locations...
Study Type: Observational
SUMMARY
Demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and Demonstrate the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from lung transplants.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Adult, Older adult
Locations
United States
Arizona
St. Joseph's Hospital and Medical Center 350 West Thomas Road, Floor 8HLT
RECRUITING
Phoenix
Florida
Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, College of Medicine
RECRUITING
Gainesville
USF Health, Morsani College of Medicine, 12901 Bruce B. Downs Blvd. MDC40
RECRUITING
Tampa
Indiana
Indiana University Methodist Hospital 1812 N. Capitol Ave Suite W131L
RECRUITING
Indianapolis
Maryland
Johns Hopkins Interventional Pulmonology, Sheikh Zayed Tower, Room 7125L, 1800 Orleans Street
RECRUITING
Baltimore
New York
Division of Pulmonary, Allergy & Critical Care Medicine Columbia University Irving Medical Center
RECRUITING
New York
Ohio
The Ohio State University Wexner Medical Center, 410 W 10th Ave
RECRUITING
Columbus
Texas
BAYLOR SCOTT & WHITE RESEARCH INSTITUTE , 3409 Worth Street
RECRUITING
Dallas
UT Southwestern Medical Center, 5939 Harry Hines Blvd.
RECRUITING
Dallas
Houston Methodist Lung Transplant Center, 6550 Fannin St., SM1001
RECRUITING
Houston
UT Health San Antonio 7703 Floyd Curl Drive, MSC: 7858
RECRUITING
San Antonio
Other Locations
Australia
The Alfred Hospital, Monash University
RECRUITING
Melbourne
Austria
Department of Thoracic Surgery, Medical University of Vienna
NOT_YET_RECRUITING
Vienna
Canada
Alberta Transplant Applied Genomics Centre, University of Alberta
RECRUITING
Edmonton
Department of Medicine, University of Alberta
RECRUITING
Edmonton
University Health Network, Toronto General Hospital
RECRUITING
Toronto
Contact Information
Primary
Konrad S Famulski, PhD DSc
konrad@ualberta.ca
1 780 782 9463
Backup
Robert Polakowski, PhD
polakows@ualberta.ca
1 780 492 5091
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2027-12
Participants
Target number of participants: 600
Related Therapeutic Areas
Sponsors
Collaborators: Natera, Inc., One Lambda
Leads: University of Alberta